As of November 2024, Sagimet Biosciences - Series A Common Stock has a market cap of $72.89M. This makes Sagimet Biosciences - Series A Common Stock the world's 23029th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $176.56M | 52.40% |
2023 | $115.85M | - |